2021/2718(DEA) Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans
Lead committee dossier:
Progress: Procedure completed - delegated act enters into force
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | ENVI |
HÄUSLING Martin ( Verts/ALE)
|
Lead committee dossier:
Legal Basis:
RoP 114-p03
Legal Basis:
RoP 114-p03Subjects
Events
2021/10/14
EP - Delegated act not objected by Parliament
2021/09/15
EP - Decision by Parliament
2021/09/08
EP - Motion for a resolution objecting delegated act
Documents
2021/07/14
EP/CSL - Initial period for examining delegated act extended at Parliament's request by 2 month(s)
2021/06/17
EP - HÄUSLING Martin (Verts/ALE) appointed as rapporteur in ENVI
2021/06/09
EP - Committee referral announced in Parliament
2021/05/26
EC - Non-legislative basic document
Documents
2021/05/26
EC - Non-legislative basic document published
Documents
2021/05/26
EP/CSL - Initial period for examining delegated act 2 month(s)
2016/03/10
EP - Matter referred back to the committee responsible
Documents
- Motion for a resolution objecting delegated act: B9-0424/2021
- Non-legislative basic document: C(2021)03552
- Non-legislative basic document published: C(2021)03552
- Non-legislative basic document: C(2021)03552
- Motion for a resolution objecting delegated act: B9-0424/2021
Votes
Objection formulée conformément à l’article 111, paragraphe 3: critères pour la désignation des antimicrobiens qui doivent être réservés au traitement de certaines infections chez l’homme - Objection pursuant to Rule 111(3): Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans - Einwand gemäß Artikel 111 Absatz 3 GO: Kriterien für die Bestimmung antimikrobieller Wirkstoffe, die der Behandlung bestimmter Infektionen beim Menschen vorbehalten bleiben müssen - B9-0424/2021 - § 6 - Am 4 #
2021/09/15 Outcome: +: 384, -: 279, 0: 27
PPE
S&D
The Left
NI
ID
ECR
RenewB9-0424/2021 - § 7 - Am 6 #
2021/09/15 Outcome: +: 322, 0: 215, -: 153
B9-0424/2021 - Après le § 7 - Am 5 #
2021/09/15 Outcome: +: 385, -: 278, 0: 27
B9-0424/2021 - Après le § 7 - Am 7/1 #
2021/09/15 Outcome: +: 497, -: 114, 0: 79
B9-0424/2021 - Après le § 7 - Am 7/2 #
2021/09/15 Outcome: -: 468, +: 209, 0: 12
B9-0424/2021 - Considérant O - Am 1 #
2021/09/15 Outcome: +: 413, -: 255, 0: 22